Daily News
-
Sjögren’s syndrome challenges start with underdiagnosis
Alan N. Baer, MD, Associate Professor of Medicine and Director of the Jerome Greene Sjögren’s Syndrome Clinic at Johns Hopkins University School of Medicine in Baltimore, will outline the differential diagnosis and an evaluation strategy for patients with salivary and lacrimal gland enlargement.
-
Board of Directors meets during the Annual Meeting
On Saturday, the ACR Board of Directors met to discuss current and future initiatives impacting its 9,500 members. Here is a summary of the meeting.
-
ILAR presentations look into technology’s power to transform care
Patients don’t fit into a rheumatoid arthritis box or osteoarthritis box, and with the hundreds of nuanced, distinct diagnoses available, one treatment plan doesn’t fit all, says Seth D. Ginsberg, Co-Founder and President of the Global Healthy Living Foundation.
-
Single-cell analysis opens several new avenues for diagnosis, treatment
In one talk during the session, Nir Hacohen, PhD, Associate Professor of Medicine at Harvard Medical School and the director of Massachusetts General Hospital’s Center for Cancer Immunotherapy, will discuss a project aimed at defining dendritic cell and monocyte subtypes that are present in humans…
-
Novel approaches could open therapeutic avenues for inflammatory arthritis
Adam Mor, MD, PhD, Assistant Professor of Medicine and Pathology at New York University School of Medicine, will discuss the role of T cells in rheumatoid arthritis.
-
Systemic sclerosis patients often face gastrointestinal woes
Tracy M. Frech, MD, MS, director of the Systemic Sclerosis Clinic at the University of Utah and a rheumatologist in the Veterans Affairs Salt Lake City Health Care System, will lead the clinical symposium Systemic Sclerosis: Assessment and Treatment of Gastrointestinal Manifestations, which starts at…
-
Evolving evidence creates novel treatment opportunities in axial spondyloarthritis
Dirk Elewaut, MD, PhD, Professor of Rheumatology and Immunology and Chair of the Department of Rheumatology at Ghent University Hospital, Belgium, will discuss the role of the interleukin 23/interleukin 17 (IL23/IL17) axis in the pathogenesis of axial spondyloarthritis.
-
Annual Meeting opens with look at workforce, big data, and mobile tools
This year’s ACR/ARHP Annual Meeting formally started Saturday afternoon with the traditional ACR/ARHP Opening Lecture and Awards. ACR President Joan M. Von Feldt, MD, MSEd, opened the session with a look at what’s happening in the field and at the association.
-
Experts review year’s rheumatologic research
Sunday morning’s Year in Review session brought together two experts who culled research published over the past year in clinical and basic science to selected studies they felt showed major trends and significant insights to the development and treatment of rheumatologic diseases, including rheumatoid arthritis,…
-
Data mining could lead to therapy advances
In the past 50 years, only one new therapy has been approved for the treatment of lupus. Peter E. Lipsky, MD, Co-Founder and Chief Executive Officer of AMPEL Bio-Solutions, Charlottesville, VA, works to change that.